Trulieve Cannabis annual stock-based compensation
2020
2021
2022
2023
2024
2025
Trulieve Cannabis Stock-Based Compensation Growth & History (TRLV)
Trulieve Cannabis's stock-based compensation was $20.5M for fiscal 2025.
View full Trulieve Cannabis company overviewTrulieve Cannabis annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $20.5M | $264,000 | +1.31% |
| 2024 | 2024-12-31 | $20.2M | $9.6M | +91.04% |
| 2023 | 2023-12-31 | $10.6M | −$7.5M | −41.65% |
| 2022 | 2022-12-31 | $18.1M | $8.9M | +95.85% |
| 2021 | 2021-12-31 | $9.3M | $6.5M | +234.68% |
| 2020 | 2020-12-31 | $2.8M | — | — |
Trulieve Cannabis quarterly stock-based compensation
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.9M | $151,000 | +2.23% |
| Q1 2026 | 2026-03-31 | $4.1M | $194,000 | +4.92% |
| Q4 2025 | 2025-12-31 | $4.0M | −$647,000 | −14.00% |
| Q3 2025 | 2025-09-30 | $5.8M | $316,000 | +5.78% |
| Q2 2025 | 2025-06-30 | $6.8M | $1.8M | +36.41% |
| Q1 2025 | 2025-03-31 | $3.9M | −$1.2M | −23.48% |
| Q4 2024 | 2024-12-31 | $4.6M | $1.5M | +46.30% |
| Q3 2024 | 2024-09-30 | $5.5M | $930,000 | +20.49% |
| Q2 2024 | 2024-06-30 | $5.0M | $4.5M | +943.58% |
| Q1 2024 | 2024-03-31 | $5.2M | $2.8M | +114.62% |
| Q4 2023 | 2023-12-31 | $3.2M | −$405,000 | −11.36% |
| Q3 2023 | 2023-09-30 | $4.5M | $247,000 | +5.75% |
| Q2 2023 | 2023-06-30 | $475,000 | −$5.2M | −91.67% |
| Q1 2023 | 2023-03-31 | $2.4M | −$2.2M | −47.39% |
| Q4 2022 | 2022-12-31 | $3.6M | −$3.5M | −49.34% |
| Q3 2022 | 2022-09-30 | $4.3M | $3.6M | +486.34% |
| Q2 2022 | 2022-06-30 | $5.7M | $5.0M | +666.53% |
| Q1 2022 | 2022-03-31 | $4.6M | $3.8M | +515.92% |
| Q4 2021 | 2021-12-31 | $7.0M | $6.5M | +1163.38% |
| Q3 2021 | 2021-09-30 | $732,000 | $209,000 | +39.96% |
| Q2 2021 | 2021-06-30 | $744,000 | $281,000 | +60.69% |
| Q1 2021 | 2021-03-31 | $741,000 | −$481,000 | −39.36% |
| Q4 2020 | 2020-12-31 | $557,000 | — | — |
| Q3 2020 | 2020-09-30 | $523,000 | — | — |
| Q2 2020 | 2020-06-30 | $463,000 | — | — |
| Q1 2020 | 2020-03-31 | $1.2M | — | — |
Trulieve Cannabis stock-based compensation trends
Over the last five fiscal years, Trulieve Cannabis's stock-based compensation increased from $2.8M to $20.5M, a change of $17.7M. The latest reported quarter, Q2 2026, shows $6.9M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trulieve Cannabis source filings ↗